fbpx Skip to main content

Relief Mental Health Sheds Light on Innovative Treatments During Mental Health Awareness Month

Instagram LIVE event spotlighting transcranial magnetic stimulation (TMS) set for May 17


OAK BROOK, Illinois – May 1, 2024 – As Mental Health Awareness Month kicks off today, Relief Mental Health aims to spotlight innovative therapies that offer hope to individuals struggling with mental health diagnoses.

In particular, the leading outpatient provider highlights transcranial magnetic stimulation (TMS) and psychedelics as breakthrough therapies that can make a significant difference for those who have not found relief through traditional methods.

TMS is a FDA-approved, non-invasive procedure that uses gentle magnetic fields to stimulate nerve cells in the brain, targeting areas associated with mood regulation. Unlike traditional treatments such as medication or therapy, TMS offers a novel approach with no systemic side effects. It has shown promising results in treating depression, obsessive-compulsive disorder (OCD), and other diagnoses, offering hope and relief to individuals who have not responded to other therapies.

SPRAVATO®, also known as esketamine, is a nasal spray medication approved by the FDA for treatment-resistant depression. It works by targeting the brain’s glutamate system, which is believed to play a role in mood regulation. As a rapid-acting antidepressant, SPRAVATO® offers a new option for individuals who have not experienced relief with conventional antidepressants. Its innovative delivery method and efficacy have made it a valuable addition to the treatment landscape for depression.

Ketamine, traditionally known as an anesthetic, has gained recognition for its rapid and profound antidepressant effects when administered in low doses via intravenous infusion. Ketamine acts on neurotransmitter systems in the brain, leading to rapid improvements in mood and alleviation of depressive symptoms. IV ketamine infusions provide a promising alternative for individuals who have not responded to other treatments or are in urgent need of relief from severe depression, bipolar depression, PTSD, anxiety and more.

“TMS, Spravato, and IV ketamine represent a new frontier in mental health treatment, offering relief to those who have struggled with traditional therapies,” said Teresa Poprawski, MD, a neuropsychiatrist and chief medical officer at Relief Mental Health. “We are committed to providing innovative, personalized solutions that can truly make a difference in our patients’ lives.”

In honor of Mental Health Month and to help educate the public on the benefits of TMS specifically, Relief Mental Health is hosting an Instagram Live event on Friday, May 17, at 10 a.m. central time. The event will take place from one of Relief Mental Health’s TMS rooms at its Oak Brook clinic, providing viewers with an inside look at this cutting-edge treatment for depression, OCD, and more. Join Relief on its Instagram platform at @reliefmentalhealth_ to learn more about TMS and how it is transforming lives.

For more information about Relief Mental Health or to schedule a consultation for any of its services, individuals can call 855.205.4764, email info@reliefmh.com.

About Relief Mental Health

Relief Mental Health is a leading outpatient provider of transcranial magnetic stimulation (TMS), psychedelics (SPRAVATO® esketamine), psychiatric medication management, and talk therapy, for the treatment of depression, obsessive compulsive disorder, anxiety and other diagnoses. Founded in January 2020 and dedicated to delivering expedited care, Relief has 10 facilities in three states. In Illinois, clinics are located in Chicago (Lakeview and West Loop), Oak Brook, Orland Park, Northbrook, Rockford, and St. Charles. Relief’s other clinics are in Warren and Red Bank, New Jersey, and West Allis, Wisconsin. With a commitment to evidence-based care, Relief Mental Health continually explores innovative treatments to provide the best possible outcomes. For more information, visit www.reliefmh.com.

Call Now